Zilico Company
Zilico is focused on developing next generation cancer diagnostics to provide real-time diagnosis for cervical cancer.
Technology:
Biomarkers of Female Cancers
Industry:
Imaging
Headquarters:
Manchester, Manchester, United Kingdom
Founded Date:
2006-01-01
Employees Number:
11-50
Funding Status:
Corporate Round
Investors Number:
8
Total Funding:
$23,546,581.00
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-02-04
Last Funding Type:
Corporate Round
Register and Claim Ownership